Recent advancements in antiviral therapy have decreased the number of patients with hepatocellular carcinoma (HCC), but obesity and diabetes remain significant risk factors for the disease. However, their impact on patient survival and cancer recurrence has been uncertain.
To investigate this, Dr. Hiroji Shinkawa’s team at Osaka Metropolitan University analyzed the postoperative outcomes of 1,644 patients with HCC who underwent liver resection, focusing on the relationships between diabetes and obesity and their effects on recovery and recurrence rates.
